Back
Aytu BioPharma Vs. Exelixis Industry Stock Comparison
Sell
43
AYTU
Aytu BioPharma
Last Price:
$2.04
Seasonality Move:
-33.44%
Buy
79
EXEL
Exelixis
Last Price:
$43.01
Seasonality Move:
7.57%
Sell
43
Aytu BioPharma (AYTU)
is a Sell
Is Aytu BioPharma a Buy, Sell or Hold?
-
The current Aytu BioPharma [AYTU] share price is $2.00. The Score for AYTU is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
AYTU is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AYTU Stock Price Chart
What is Aytu BioPharma's stock price today?
-
The Aytu BioPharma share price today is $2.00Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AYTU is experiencing slight buying pressure.
AYTU Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.1 | Buy |
Relative Strength Index (14 RSI): | 60.38 | Buy |
Chaikin Money Flow: | 2410906 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.31 - 2.05) | Buy |
Bollinger Bands (100): | (1.1 - 1.72) | Buy |
EXEL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.05 | Buy |
Relative Strength Index (14 RSI): | 59.04 | Buy |
Chaikin Money Flow: | 2139916 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (38.48 - 44.58) | Buy |
Bollinger Bands (100): | (34.03 - 40.61) | Buy |
AYTU Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.74 | Buy |
20-day SMA: | 1.79 | Buy |
50-day SMA: | 1.39 | Buy |
200-day SMA: | 1.71 | Buy |
8-day EMA: | 1.76 | Buy |
20-day EMA: | 1.71 | Buy |
50-day EMA: | 1.54 | Buy |
200-day EMA: | 1.74 | Buy |
EXEL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 42.65 | Buy |
20-day SMA: | 42.44 | Buy |
50-day SMA: | 39.01 | Buy |
200-day SMA: | 33.94 | Buy |
8-day EMA: | 42.69 | Buy |
20-day EMA: | 41.99 | Buy |
50-day EMA: | 39.94 | Buy |
200-day EMA: | 34.41 | Buy |
Aytu BioPharma Earnings Growth & AYTU Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Exelixis Earnings Growth & EXEL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.01 per share, an increase this year of $0.66 per share, and an increase next year of $0.46 per share.
Aytu BioPharma Technical Analysis
May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
23 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Exelixis Technical Analysis
May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
23 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |